Saturday 5 April 2003
Organizers K. Mašek (Prague, Tsjech Republic)
J.W. Hadden (Tampa, USA)
Sponsor ISIP (International Society of Immunopharmacology), Tsjech Republic

Immunopharmacology: from laboratory bench to clinical practice

Session I
Chair K. Mašek (Prague, Tsjech Republic) Abstract No.
09.40 – 10.10 Combination immunotherapy of cancer
J.W. Hadden (Tampa, USA)
10.10 – 10.40 Neuroendocrine immune interactions in health and disease
K. Mašek, J.W. Hadden (Prague, Tsjech Republic/Tampa, USA)
10.40 – 11.00 Discussion
11.00 – 11.15 coffee break
11.15 – 11.45 Vaccine engineering for Th1 responses
F. Audibert (Paris, France)
11.45 – 12.15 The immunopharmacology of infectious diseases
K.N. Masihi (Berlin, Germany)
12.15 – 12.30 The imidazoquinoline R-848 shifts human allergen-specific Th2 cells into Th1 effectors
F. Brugnolo, L. Filì, S. Sampognaro, L. Cosmi, F. Liotta, F. Annunziato, C. Manuelli, E. Maggi, S. Romagnani, and P. Parronchi (Florence, Italy)
12.30 – 12.45 In vitro testing for immunomodulatory capacity of red and white wines
G. Neurauter, B. Wirleitner, K. Schroecksnadel and D. Fuchs (Innsbruck, Austria)
12.45 – 13.00 Discussion
13.00 End of workshop


AFP-receptor – the universal target for targeted drug delivery
S. Severin, M. Nitsvetov, E. Moskaleva, A. Rodina, O. Makarova., V. Stepanov, Yu. Belousova, G. Posypanova, A. Karaulov, and E. Severin (Moscow, Russia)

Treatable effect of Plaferon LB on ConA induced hepatitis
M.A. Kvezereli, T.I. Chikovani, and T. Sanikidze (Tbilisi, Georgia(NIS))